Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 24

Trial Status

Completed8

Role Distribution

Principal Investigator8
PI Rate100%

Activity Timeline

Clinical Trials (8)

NCT01519063Phase 2Completed
Naltrexone and Memantine Effects on Alcohol Drinking Behaviors
Alcohol Drinking
PrincipalinvestigatorStart date: 2012-01-01
NCT00630955Phase 2Completed
Family History Study of Alcohol Consumption Using Memantine
Alcohol Drinking
Principalinvestigator
NCT01145001Not ApplicableCompleted
Enhancing a High School Based Smoking Cessation Program
Nicotine Dependence
Principalinvestigator
NCT01173835Phase 1Completed
Incentive-based Intervention for Smoking Cessation and Prevention in High Schools
Tobacco Prevention and Cessation
Principalinvestigator
NCT01624428Phase 1Completed
Varenicline on Reward Responses and Cognition in Adolescent Smokers
Tobacco Use Disorders
Principalinvestigator
NCT01625611Phase 1Completed
Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors
Alcohol Drinking
Principalinvestigator
NCT01625637Phase 2Completed
Tobacco Approach Avoidance Training for Adolescent Smokers-2
Tobacco Use Disorder
Principalinvestigator
NCT01625767Phase 2Completed
Tobacco Approach Avoidance Training for Adolescent Smokers-1
Tobacco Use Disorder
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

John R Hughes, MD

University of Vermont

Related
7 trials

Shared therapeutic areas:

Nicotine DependenceTobacco Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)National Institutes of Health (NIH)
Similarity Score15%

Dorothy Hatsukami, PhD

University of Minnesota

Related
13 trials

Shared therapeutic areas:

Tobacco Use DisorderNicotine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Elliot Stein, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
20 trials

Shared therapeutic areas:

Nicotine DependenceTobacco Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Neal L Benowitz, MD

University of California, San Francisco

Related
10 trials

Shared therapeutic areas:

Nicotine DependenceTobacco Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)National Institutes of Health (NIH)
Similarity Score15%

Caryn Lerman, PhD

University of Pennsylvania

Related
8 trials

Shared therapeutic areas:

Nicotine DependenceTobacco Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

John R Knight, MD

Boston Children's Hospital

Related
9 trials

Shared therapeutic areas:

Nicotine DependenceTobacco Use Disorder

Worked with same sponsors:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Similarity Score15%

Yves Donazzolo, MD

Eurofins Optimed

Related
8 trials

Shared therapeutic areas:

Nicotine Dependence
Similarity Score8%

Vijay A Ramchandani, Ph.D.

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Related
9 trials

Shared therapeutic areas:

Alcohol Drinking

Worked with same sponsors:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)National Institute on Drug Abuse (NIDA)
Similarity Score8%

Stephen J Heishman, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
7 trials

Shared therapeutic areas:

Nicotine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score8%

Mehmet Sofuoglu, M.D.,Ph.D.

Yale University

Related
8 trials

Shared therapeutic areas:

Nicotine Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)Yale University
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT01519063Phase 2PrincipalInvestigator

Naltrexone and Memantine Effects on Alcohol Drinking Behaviors

Alcohol Drinking
Completed
NCT00630955Phase 2PrincipalInvestigator

Family History Study of Alcohol Consumption Using Memantine

Alcohol Drinking
Completed
NCT01145001Not ApplicablePrincipalInvestigator

Enhancing a High School Based Smoking Cessation Program

Nicotine Dependence
Completed
NCT01173835Phase 1PrincipalInvestigator

Incentive-based Intervention for Smoking Cessation and Prevention in High Schools

Tobacco Prevention and Cessation
Completed
NCT01624428Phase 1PrincipalInvestigator

Varenicline on Reward Responses and Cognition in Adolescent Smokers

Tobacco Use Disorders
Completed
NCT01625611Phase 1PrincipalInvestigator

Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors

Alcohol Drinking
Completed
NCT01625637Phase 2PrincipalInvestigator

Tobacco Approach Avoidance Training for Adolescent Smokers-2

Tobacco Use Disorder
Completed
NCT01625767Phase 2PrincipalInvestigator

Tobacco Approach Avoidance Training for Adolescent Smokers-1

Tobacco Use Disorder
Completed

All 8 trials loaded